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Background: Hyperhomocysteinemia has been associated with vascular disease in many epidemiologic studies, but only a
few have reported on the relation between hyperhomocysteinemia and aneurysms of the abdominal aorta (AAAs).
Although these studies showed higher homocysteine concentrations in patients with AAA than in controls, little attention
had been given to possible confounding factors. Most patients with AAA are of older age, have an impaired renal function,
and have other risk factors for cardiovascular disease. This matched case–control study investigated the relation between
homocysteine concentration (before and after methionine loading) and AAA, taking into account possible confounders
such as age, sex, and concentrations of creatinine and B vitamins.
Methods: Patients with a history of AAA were recruited from the outpatient clinic; 60% had already undergone surgery for
their AAA. They were asked to invite a friend or neighbor to participate as a control subject (age-matched and
sex-matched). Concentrations of homocysteine, vitamin B6, vitamin B12, folate, and creatinine were determined in the
fasting state, and blood was taken for methylenetetrahydrofolate reductase (MTHFR) mutation analysis. Six hours after
oral methionine loading, the postmethionine load homocysteine concentration was determined.
Results: Univariate analysis showed an odds ratio (OR) of 2.2 (95% confidence interval (CI), 0.9 to 5.5) for the risk of AAA
for the highest quartile of homocysteine concentration. After adjustment for creatinine, the OR was markedly reduced to 1.24
(95% CI, 0.42 to 3.66), and this risk further attenuated in the multivariate analysis. Univariate analysis of the B vitamins
showed an increased risk of AAA for the bottom quartile of vitamin B6 (OR, 3.75; 95% CI, 1.22 to 11.54), which even
increased after adjustments. The relative risk associated with the MTHFR 677TT polymorphism was 2.1 (95% CI, 0.9 to 5.3).
Conclusion: Vitamin B6, but not homocysteine, is an independent risk factor for AAA. The role of vitamin B6 in the
pathogenesis of AAA needs to be further elucidated. (J Vasc Surg 2007;45:701-5.)Abdominal aortic aneurysm (AAA) is present in 4.3% to
8.8% of men aged65 years, and rupture of AAA causes 1%
to 2% of all deaths in men aged 65 years in Western
countries.1 The incidence of AAA is increasing, partly ow-
ing to ageing of the population. The insights on the patho-
genesis of AAA have been changed in recent decades. In the
past, AAA was regarded as a consequence of atherosclero-
sis.1,2 More recent studies suggest a significant role for
matrix metalloproteinases (MMPs) in the pathogenesis of
AAA.3,4 MMPs regulate the turnover of extracellular ma-
trix proteins. Tissue inhibitors of MMPs (TIMPs) inhibit
active enzymes and are also present in increased amounts in
the wall of the aneurysm. So the net effect in tissues
depends on the balance between MMPs and TIMPs. In
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Hyperhomocysteinemia is thought to be a risk factor
for arterial vascular disease5 and venous thrombosis.6 Stud-
ies on the methylenetetrahydrofolate reductase (MTHFR)
677TT genotype suggested that this relationship was causal,7
but two recently published trials did not show an effect of
homocysteine-lowering with B vitamins on cardiovascular
end points.8,9 Only a few studies have been published on
the relation of homocysteine and AAA.10-13 Although
these studies showed that patients with AAA have higher
plasma concentrations of homocysteine, they did not take
into account that homocysteine concentration is depen-
dent on several other factors such as age, sex, B vitamins,
and renal function.
We evaluated the role of homocysteine in AAA, taking
into account possible confounders by initiating a case–
control study in patients with AAA and control subjects of
the general population. In addition, we studied determi-
nants of homocysteine concentration, such as B vitamins
and creatinine, performed a methionine-loading test, and
determined the MTHFR genotype.
METHODS
Study population. The study protocol has been de-
scribed before.14 Briefly, all patients with AAA who visited
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a regional hospital in a city of 200,000 inhabitants in The
Netherlands, were invited to take part in this study. We
invited 149 patients who had already undergone surgery
for their AAA as well as patients who had not had surgery
for their AAA (defined as ultrasonographically proven in-
frarenal aortic diameter 30 mm). Of these, 89 patients
wanted to participate (response rate, 60%), of whom 53
(60%) had already undergone surgery.
The concentrations of homocysteine, B vitamins, and
folate are determined mostly by the factors of age, diet,
smoking, and for homocysteine, especially, renal function.
We do not think that these are influenced by surgery for
AAA. We therefore grouped the patients who underwent
surgery and the patients who did not have surgery for their
AAA.
Each patient was asked to invite a friend or neighbor of
the same sex and within a 5-year age range to serve as a
control. We failed to match four patients. For three, we
included a family member as a control that was matched to
another patient. We could not match one 94-year-old
woman, and she was excluded. Our final study population
consisted of 88 patients with AAA and 88 control subjects
matched for age and sex.
All control subjects underwent ultrasonography of the
abdominal aorta. Control subjects with an aortic diameter
30 mm were excluded. All subjects were asked to com-
plete a questionnaire about medical and family history,
medication use (including vitamins), and smoking habits.
In The Netherlands cereal grains are not supplemented
with folate. Blood pressure was measured in the supine
position, three times with a mercury sphygmomanometer,
after a resting period of 10 minutes. All participants gave
written informed consent, and the TweeSteden Hospital
Medical Ethics Committee approved the study protocol.
Determinants of homocysteine concentration, me-
thionine loading test, and MTHFR genotype. After an
overnight fast, blood was taken for determination of plasma
concentration of homocysteine, vitamin B6 (pyridoxal
5-phosphate), B12 (cobalamin), folate, and creatinine, as
well as MTHFR mutation analysis. Then subjects under-
went a methionine-loading test. Six hours after an oral
loading dose of L-methionine (0.1 g/kg body weight in
200 mL orange juice),15 blood was taken to determine a
postmethionine load homocysteine concentration.
Total homocysteine concentrations were measured ac-
cording to the method described by Araki and Sako.16
Folate and cobalamin concentrations were measured with
the competitive protein-binding assay on the Technicon
Immuno 1 System (Technicon Instruments, Tarrytown,
NY). Determination of pyridoxal 5-phosphate was per-
formed by high performance liquid chromatography ac-
cording to Ubbink et al.17 DNA was isolated from the buffy
coat, and mutation analysis was accomplished by means of
polymerase chain reaction as described elsewhere.18,19 The
primers generate a 198-bp fragment. The MTHFR C¡T
substitution at bp 677 creates a HinfI recognition se-
quence. If the mutation is present, HinfI digests the198-bp fragment into a 175-bp and a 23-bp fragment. The
fragments were analyzed by polyacrylamide gel electro-
phoresis.
Statistical analysis. General baseline characteristics
were compared using the Student unpaired two-tailed t test
and 2 test. To investigate the relative risks, we calculated
crude and adjusted matched odds ratios (OR) and 95%
confidence intervals (CI) with a conditional logistic regres-
sion model using Stata 8 (StataCorp, College Station, Tex).
Concentrations of homocysteine, vitamin B6, B12, and
folate were divided into quartiles and analyzed as categoric
variables to evaluate both the risk and dose-response rela-
tionship. We calculated the risk (crude ORs) to have an
AAA for the different quartiles and used either the top or
bottom quartile as the reference category. We used a mul-
tivariate model to adjust this OR first for creatinine, then
for each other, and for smoking. Finally, we adjusted the
ORs for the classic risk factors for cardiovascular disease
such as hypertension and dyslipidemia.
RESULTS
The median age was 69 years (range, 45 to 85 years) for
the patient group and 67 years (range, 44 to 83 years) for
the control group. The male/female ratio was 81:7. An
open surgical procedure was done in 53 (60%) of the 88
Table I. Characteristics of patients with abdominal aortic
aneurysm and control subjects
Characteristic
Patients
(n  88)
Controls
(n  88) P
Age in years (range) 69 (45-85) 67 (44-83) NS
Male/female 81:7 81:7 NS
Aneurysm
Not operated 35
Operated 53
Family history of aneurysm 16 9 NS
History
Myocardial infarction 26 9 .01
Cerebrovascular disease 9 4 NS
Pulmonary embolism 2 3 NS
COPD 24 13 .04
Peripheral vascular disease 19 4 .01
Cigarette smoking
(pack-year  SD)* 34  33 23  22 .01
Mean blood pressure
Systolic, mm Hg  SEM 159  2.4 158  2.7 NS
Diastolic, mm Hg  SEM 85  1.2 87  1.2 NS
Creatinine (mol/L) 101.4 90.5 .01
ACE inhibitors 19 10 .07
-blockers 25 13 .03
Statins 22 6 .01
Vitamin status
Use of B vitamins 17 16 NS
Vitamin B6 (nmol/L) 67.2 75.7 .08
Vitamin B12 (pmol/L) 229.5 263.5 .04
Folate (nmol/L) 13.1 13.7 NS
NS, Not significant; COPD, chronic obstructive pulmonary disease; SEM,
standard error of the mean; ACE, angiotensin-converting enzyme.
*A pack-year was defined as smoking 20 cigarettes/day for 1 year.patients. Elective surgery was performed in 40 patients.
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Median time after surgery was 36 months (range, 4 to 132
months). The other 35 patients were followed up with
ultrasonography. Other general characteristics of the pa-
tient and control group are summarized in Table I.
In the univariate analysis (Table II), we found an OR of
2.2 (95% CI, 0.9 to 5.5) for the risk of AAA for the highest
quartile of homocysteine concentration. After adjustment
for creatinine concentration, this risk estimate was mark-
edly reduced to an OR of 1.24 (95% CI, 0.42 to 3.66), and
after adjustments for B vitamins and smoking, the risk for
AAA with a high homocysteine concentration was further
attenuated. Univariate analysis of the B vitamins, as deter-
minants of the homocysteine concentration, showed an
increased risk for AAA for the bottom quartile of vitamin
B6, B12, and folate (Table II). After adjustment for creat-
inine concentration, the risk for AAA was even more pro-
nounced for the bottom quartile of B6 (OR, 6.92; 95% CI,
1.63 to 29.28), which remained after adjustments for
smoking and concentrations of homocysteine, vitamin
B12, and folate.
Although it is not evident whether hypertension and
hypercholesterolemia are risk factors for AAA, we addition-
ally corrected the OR for both factors, which did not
change the high relative risk on AAA (data not shown).
Subgroup analysis of patients who underwent surgery
and those who did not showed comparable results. The
vitamin B6 concentration and distribution over the quar-
tiles is presented for cases and controls in the Fig.
Univariate analysis of the postmethionine load homo-
cysteine concentration showed no evident risk for AAA for
the postload homocysteine concentration (Table III). After
Table II. Crude and adjusted odds ratios for the risk of ab
vitamin B6, B12, and folate concentrations
Variables (in quartiles) Crude OR (95% CI)
Plasma homocysteine (mol/L)
9.33 reference category
9.33-11.8 2.02 (0.87-4.68)
11.8-15.1 2.06 (0.79-5.34)
15.1 2.22 (0.90-5.49)
Plasma vitamin B6 (nmol/L)
55 3.75 (1.22-11.54)
55-66 5.11 (1.78-14.70)
66-79 3.40 (1.24-9.34)
79 reference category
Plasma vitamin B12 (pmol/L)
171.5 3.16 (1.23-8.14)
171.5-224.5 2.54 (0.99-6.52)
224.5-301.5 1.16 (0.49-2.75)
301.5 reference category
Plasma folate (nmol/L)
8.73 2.13 (0.86-5.24)
8.73-11.6 1.55 (0.69-3.50)
11.6-15.5 1.75 (0.78-3.93)
15.5 reference category
OR, Odds ratio; CI, confidence interval.
*Adjusted for creatinine concentration.
†Adjusted for creatinine concentration, for each other, and smoking.correction for creatinine concentration, the ORs also atten-uated; after adjustments for B vitamins, no relation was
found between the postload homocysteine concentration
and the risk for AAA.
Finally, we evaluated the 677 C¡T mutation in the
MTHFR gene, which is a common cause of hyperhomo-
cysteinemia. Of the 85 patients, 15 were homozygous for
the 677 C¡T mutation compared with seven of the 86
control subjects. We calculated a matched OR of 2.1 (95%
CI, 0.9 to 5.3).
DISCUSSION
Although homocysteine concentration seems to be a
inal aortic aneurysm for quartiles of homocysteine,
Adjusted OR* (95% CI) Adjusted OR† (95% CI)
reference category reference category
1.94 (0.78-4.80) 1.09 (0.31-3.84)
1.45 (0.49-4.26) 1.15 (0.26-5.10)
1.24 (0.42-3.66) 0.78 (0.17-3.62)
6.92 (1.63-29.28) 19.43 (2.12-177.78)
7.64 (2.19-26.61) 17.66 (2.95-105.78)
4.18 (1.33-13.13) 5.61 (1.38-22.82)
reference category reference category
3.26 (1.14-9.33) 0.95 (0.19-4.70)
2.53 (0.86-7.37) 1.52 (0.33-6.96)
1.02 (0.40-2.61) 0.42 (0.11-1.60)
reference category reference category
1.76 (0.65-4.77) 0.51 (0.10-2.65)
1.23 (0.50-3.02) 0.46 (0.11-1.92)
1.41 (0.59-3.39) 0.99 (0.32-3.08)
reference category reference category
Fig. Dot plot of vitamin B6 concentration and distribution in
quartiles, for controls and cases with abdominal aortic aneurysm.domrisk factor for AAA in univariate analysis, several indications
and fo
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factors, especially renal function. Homocysteine is strongly
increased in renal dysfunction, and many patients with AAA
have impaired renal function. That homocysteine after
methionine loading (which is less influenced by renal func-
tion) is not a risk factor for AAA supports the hypothesis
that homocysteine is not causally related to AAA, because
in other forms of cardiovascular disease, fasting and post-
methionine load homocysteine concentrations are both risk
factors.20
A few other studies on the relation between hyperho-
mocysteinemia and AAA have found an impressive risk for
AAA, with ORs of 8 to 36,10-13 but these studies did not
take renal function into account. To determine whether a
possible association of homocysteine with AAA could have
a causal relationship without influence of confounding
factors, we analyzed the MTHFR genotype according to
the principles of Mendelian randomization.21 Our study
showed a risk estimate for AAA with the MTHFR 677TT
genotype of 2.1 (95% CI, 0.9 to 5.3). Two other studies
also investigated the relation of homocysteine and AAA, as
well as the MTHFR-genotype and AAA in the same popu-
lation.10,13 They also saw only a modest, not significant,
relation between the MTHFR 677TT genotype and the
occurrence of AAA.
In our multivariate analysis, the high risk-estimate for
AAA with a low concentration of vitamin B6 is striking and
remained after adjustments for the other variables and
smoking. Earlier, the risk of a low B vitamin concentration
was attributed to a higher homocysteine concentration, but
in our multivariate analysis the high risk of AAA with a low
vitamin B6 was independent of the basal homocysteine
concentration. The concentration of B vitamin is not de-
pendent on age, sex, renal function, or cardiovascular co-
morbidity and seems therefore to be less influenced by
possible confounding factors. Other studies have also re-
ported a homocysteine-independent risk of low vitamin B6
for arterial vascular disease.22,23
How could a low vitamin B6 status affect the abdomi-
nal wall? Collagen and elastin are major components of the
vascular wall. In aneurysms, the elastic lamellae of the
vascular wall are degraded, and collagen production is
enhanced. Pyridoxal 5-phosphate is an important cofactor
for lysyl oxidase, an enzyme responsible for cross-linking
Table III. Crude and adjusted odds ratios for the risk of a
load homocysteine concentration
Quartiles (mol/L) Crude OR (95% CI)
27.7 reference category
27.7-33.4 0.99 (0.40-2.49)
33.4-40.9 2.95 (1.24-6.98)
40.9 1.48 (0.63-3.46)
OR, Odds ratio; CI, confidence interval.
*Adjusted for creatinine concentration.
†Adjusted for the concentration of creatinine, vitamin B6, B12, and folate,collagen and elastin. Animal studies have reported thatpyridoxal 5-phosphate depletion inhibits lysyl oxidase.24,25
Homocysteine did not inhibit lysyl oxidase. Pyridoxine
deficiency was also responsible for alterations in bone col-
lagen26 and for loss of connective tissue integrity.27 Further
studies are needed to elucidate the role of vitamin B6 in the
risk of AAA.
In our study, 53 of 88 patients had already undergone
surgery for their aneurysm. We do not think that surgery
directly influences homocysteine or vitamin concentra-
tions. However, patients with large aneurysms who un-
dergo surgery do more often have a decrease in renal
function that results in an increase in homocysteine (but
not vitamin) concentration. The MTHFR genetic poly-
morphism is not influenced by surgery.
CONCLUSION
Fasting homocysteine concentration was associated
with AAA, but after adjustment for creatinine and B vita-
min status, this association disappeared. However, a low
concentration of vitamin B6 remained a risk factor for the
occurrence of AAA. The role of vitamin B6 in the patho-
genesis of AAA needs to be further elucidated.
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